Tone mix
Week by week 52 weeks
Share of Novo-Nordisk A/S's 2,425 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Dec 22, 2025 · tone +72Biotech Stocks Shine After Hours: Novo Nordisk, IDEAYA, Healthcare Triangle Among Gainers+74
- Week of Jun 15, 2026 · tone -46Hacking group claims major hack of Novo Nordisk and attempted $25 million extortion-70
- Week of Apr 13, 2026 · tone +52Novo Nordisk signs deal with OpenAI to develop new drugs+50
- Week of Feb 2, 2026 · tone -34Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk-47
- Week of Jun 1, 2026 · tone +3Baystreet.ca - Why Comcast, Bonds, and Novo Nordisk Keep Falling-42
- Week of Apr 20, 2026 · tone +61Novo Nordisk Announces Partnership with OpenAI+42
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Novo-Nordisk A/S in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 14 | +32 |
| Last 30 sessions | 129 | +10 |
| Last 90 sessions | 497 | +9 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone +42: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.theepochtimes.com · 1 outletJudge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo NordiskPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Judge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo Nordisk | www.theepochtimes.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
2 headlines, average tone +35: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.fool.com · 2 outletsAmgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026?Neutral
- www.foreignpolicyjournal.com · 1 outletNovo Nordisk (NYSE: NVO) Has Deployed Over DKK 11 Billion Of Its DKK 15 Billion Buyback With Months Still To RunPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026? | www.fool.com | 2 | Neutral |
| Novo Nordisk (NYSE: NVO) Has Deployed Over DKK 11 Billion Of Its DKK 15 Billion Buyback With Months Still To Run | www.foreignpolicyjournal.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 27, 2026
2 headlines, average tone -21: 1 positive, 0 neutral and 1 negative. Showing all 2.
- www.claimsjournal.com · 1 outletNovo Nordisk Loses Court Ruling Over Eli Lilly Obesity Drug AdsNegative
- www.business-standard.com · 1 outletUS judge rejects Novo Nordisk bid to halt Eli Lilly's weight-loss drug adsPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novo Nordisk Loses Court Ruling Over Eli Lilly Obesity Drug Ads | www.claimsjournal.com | 1 | Negative |
| US judge rejects Novo Nordisk bid to halt Eli Lilly's weight-loss drug ads | www.business-standard.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.foreignpolicyjournal.com · 1 outletNovo Nordisk (NYSE: NVO) Expands AI Drug Discovery Push Through OpenAI's Rosalind PlatformPositive
- www.tickerreport.com · 1 outletCritical Review: Novo Nordisk A/S (NYSE:NVO) and Astellas Pharma (OTCMKTS:ALPMY)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novo Nordisk (NYSE: NVO) Expands AI Drug Discovery Push Through OpenAI's Rosalind Platform | www.foreignpolicyjournal.com | 1 | Positive |
| Critical Review: Novo Nordisk A/S (NYSE:NVO) and Astellas Pharma (OTCMKTS:ALPMY) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletBristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 VolatilityNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Novo-Nordisk A/S, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.